Clinical Trial Update: Neoadjuvant Embolization and Cytoreduction in Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant embolization and cytoreduction in prostate cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Srinivas Raman | Conditions: Prostate Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING